NeurologyLive Friday 5 — February 14, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 14, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Podcast: No Relief for Rising MS Drug Prices
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Daniel Hartung, PharmD, MPH.
2: New Guidelines for Addressing Sleep Disturbance in Autism Spectrum Disorder
Following the 2011 guideline development process, this 2020 guideline focused on addressing a number of types of sleep disturbance in children and adolescents with autism spectrum disorder.
3: Can Better Stress Coping Limit Tau Deposition?
Stress coping abilities may have a direct impact on the early accumulation of tau pathology.
4: Advice for Neurologists Treating Patients With Sialorrhea
Expert panelists provide advice to neurologists to incorporate the use of botulinum toxic injections into their practice to treat sialorrhea in Parkinson disease.
5: Smartphones in the Clinic: How Patient Videos Can Change Seizure Diagnosis
William O. Tatum, DO, director, Comprehensive Epilepsy Center, and professor of neurology, Mayo Clinic College of Medicine & Health Sciences, discussed the additive value of smartphone video technology in diagnosing epilepsy.
